13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 51 holding rows worth $395,154,620.
- Accession
- 0001214659-25-016415
- Filer
- CIK 1482416
- Filed
- 2025-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 51 entries on the cover page, a total value of $395,154,620 stated on the cover page (in dollars after the unit check, H1), rows summing to $395,154,620 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXIMUS INC | 577933104 | COM | 557,615 | $50,949,283 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 786,526 | $38,854,384 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 562,703 | $26,559,582 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 577,750 | $22,734,463 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 674,840 | $20,245,200 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 284,787 | $18,818,725 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 177,300 | $14,880,789 | dollars as filed | |
| SCHEIN HENRY INC | 806407102 | COM | 219,207 | $14,548,769 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 387,600 | $13,829,568 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 844,000 | $13,698,120 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 225,114 | $12,192,174 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 268,873 | $11,604,559 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 190,764 | $11,571,744 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 198,035 | $9,652,226 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 1,498,095 | $8,374,351 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 683,819 | $8,328,915 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 1,772,601 | $7,976,705 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 174,841 | $7,282,128 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 514,947 | $7,204,109 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 185,265 | $5,502,371 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 413,829 | $5,346,671 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 55,723 | $5,104,227 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 307,181 | $4,982,476 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 40,057 | $4,901,375 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 320,307 | $4,827,026 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 2,075,139 | $4,420,046 | dollars as filed | |
| SHOULDER INNOVATIONS INC | 82537J108 | COMMON STOCK | 350,000 | $4,392,500 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,636,548 | $3,691,167 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 189,199 | $3,558,833 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 124,230 | $3,380,298 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 335,937 | $3,292,183 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,369,748 | $2,986,051 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 478,343 | $2,731,339 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 726,851 | $2,594,858 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 829,178 | $2,578,744 | dollars as filed | |
| NEUROONE MED TECHNOLOGIES CORP COM | 64130M209 | Stock | 2,360,635 | $2,097,660 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,427,495 | $1,855,744 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 130,628 | $1,512,672 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,341,636 | $1,299,777 | dollars as filed | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 2,315,749 | $1,009,203 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 636,300 | $948,087 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 72,173 | $917,319 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 122,889 | $600,927 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 785,824 | $549,920 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,839 | $233,859 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 163,679 | $201,325 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 112,223 | $165,529 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 10,100 | $75,851 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 10,940 | $64,108 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $14,440 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $12,240 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-016415 | this filing | 2025-11-13 | acceptance time not in the bulk data set |